0001209191-15-003151.txt : 20150108
0001209191-15-003151.hdr.sgml : 20150108
20150108162907
ACCESSION NUMBER: 0001209191-15-003151
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150106
FILED AS OF DATE: 20150108
DATE AS OF CHANGE: 20150108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVEO PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001325879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 650 E. KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 6172995000
MAIL ADDRESS:
STREET 1: 650 E. KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAILEY MICHAEL P
CENTRAL INDEX KEY: 0001255856
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34655
FILM NUMBER: 15516730
BUSINESS ADDRESS:
STREET 1: IMCLONE SYSTEMS INCORPORATED
STREET 2: 180 VARICK STREET, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 6466385078
MAIL ADDRESS:
STREET 1: IMCLONE SYSTEMS INCORPORATED
STREET 2: 180 VARICK STREET, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-01-06
0
0001325879
AVEO PHARMACEUTICALS INC
AVEO
0001255856
BAILEY MICHAEL P
C/O AVEO PHARMACEUTICALS, INC.
650 E. KENDALL STREET
CAMBRIDGE
MA
02142
1
1
0
0
President & CEO
Common Stock
2015-01-06
4
D
0
13200
0.00
D
21519
D
Common Stock
2015-01-07
4
S
0
4484
0.8003
D
17035
D
Stock Option (right to buy)
0.84
2015-01-06
4
A
0
900000
0.00
A
2025-01-06
Common Stock
900000
900000
D
Shares underlying such disposition to the issuer were forfeited by the reporting person pursuant to the terms of an award of restricted stock granted to the reporting person on June 26, 2013 in connection with the determination of the issuer's Compensation Committee that certain specified strategic performance objectives were not met.
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2013, which was implemented to cover taxable events related to the partial vesting of certain restricted stock.
The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.78 to $0.82, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
This option vests in equal monthly installments from January 6, 2015 through January 6, 2019.
/s/Joseph D. Vittiglio, Esq., attorney-in-fact
2015-01-08